Welcome to the era of mindful medicine.

Psilera delivers therapies designed to change the way the world thinks.

The Latest From The Lab:

Psilera wins

$2 Million grant to advance AUD

treatments from the

National Institutes of Health

Read the full press release here!

Psilera

At A

Glance

  • We have created and developed six separate serotonergic compound families.

  • Two patents have been issued from the USPTO covering over 1 million novel compounds. Several more patents expected by 1H 2024.

  • The Psilera leadership team has over 100 years of combined experience in the biotech and pharmaceutical industries.

  • Our best-in-class proprietary compound library has coverage for over 1 million novel compounds.

  • Psilera’s co-founders bring over $1.5B in cumulative value created from prior start-ups.

Psilera is revolutionizing how small molecule drug discovery is done, giving rise to more patient-centric therapy options for those suffering from neurological conditions.

Based on the current pipeline, our focus is on hard-to-treat disorders, many of which have no currently available treatments, such as Frontotemporal Dementia (FTD).

UPCOMING EVENTS

UPCOMING EVENTS

January 11 -13

February 2 - 3


Tampa, FL

February 28 - 29


Boston, MA


San Francisco, CA

Neuroscience Innovation Forum & JPM

Chris Witowski, PhD, Co-Founder & CEO, will be speaking at the 9th Annual Neuroscience Innovation Forum. The “Meeting the Promise of Psychedelics Panel: Expected Trends for 2026” is set to offer critical insights into the year ahead for the neuroplastogen and psychedelic industries. He will be joined by Co-Founder and CSO Jackie von Salm, PhD to meet with development partners at the JP Morgan Healthcare Conference. To connect with our team while they are in California, please contact info@psilera.com to arrange a time.

Life Science Women’s Conference

Jackie von Salm, PhD will be speaking at the Life Science Women’s Conference in early February. Hosted at the University of South Florida, the event is centered on sharing insights from women leaders across biotech, medtech, and pharma. Discussions will focus on women's enlightenment, funding & entrepreneurship, the latest FEM tech, AI and digital technology, women's health & wellness, career development, networking, mentorship, and empowerment.

Neuroscience Innovation

Pharma Partnering Summit

In the spring, Jackie von Salm, PhD will be speaking at the Neuroscience Innovation Pharma Partnering Summit in Boston. Focused on accelerating collaboration and partnership across neurology and psychiatry, the Summit will allow key opinion leaders in the CNS space the opportunity to forge new connections. If you will be in Boston for the event and would like to connect, please message us at info@psilera.com.